Golden State Medical Supply Inc. recalls Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated
FDA-confirmed impurity in Golden State Medical Supply's Losartan Potassium Tablets may exceed safe levels. Recalled due to CGMP deviations. Check NDC 60429-316-30 for affected products.
Recall notice
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
Contact the company & request your remedy
What happened, in plain English
Golden State Medical Supply is recalling Losartan Potassium Tablets 25 mg 30-count bottles (NDC 60429-316-30) because FDA labs found an impurity in the product that could exceed safe levels. This recall is for prescription-only medication. Read more at govinfonow.com/recall/38862-golden-state-losartan-tablets-recall-impurity-risk-in-finished-product.
Source Summary by GovInfoNow · govinfonow.com/recall/38862-golden-state-losartan-tablets-recall-impurity-risk-in-finished-product · Updated October 5, 2026 · FDA enforcement record: FDA #D-1282-2019
Cite this page
“Golden State Losartan Tablets Recall: Impurity Risk in Finished Product.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38862-golden-state-losartan-tablets-recall-impurity-risk-in-finished-product. Based on FDA recall #D-1282-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1282-2019%22&limit=1).
Why it’s dangerous
FDA labs detected an impurity called N-Methylnitrosobutyric acid (NMBA) in the medication. This impurity was found at levels above the interim acceptable daily intake, which could potentially cause health issues if consumed regularly.
Who’s affected
Prescription holders of Losartan Potassium Tablets 25 mg 30-count bottles with NDC 60429-316-30 are affected. Patients taking this medication for blood pressure should be cautious as the impurity may pose health risks.
How to tell if you have this one
Check for the NDC code 60429-316-30 on the product label. The product is a prescription-only medication sold by Golden State Medical Supply Inc. with expiration dates of February 2020.
- Brand
Golden State Medical Supply- Category
Drug
All 5 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
IL, MI, MN, PA, TN, TX. Two (2) US government and one (1) Veterans Affairs accounts. No foreign accounts.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1282-2019 | Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated; GS017981 exp 02/2020, GS016958 exp 02/2020, GS017341 exp 02/2020 | 11,668 HDPE bottles |
| D-1283-2019 | Losartan Potassium Tablets USP 25 mg 90 count bottle NDC 60429-316-90 Rx only GSMS Incorporated; GS015172 exp 06/2019 GS017634 02/2020, GS017653 exp 02/2020, GS017980 exp 02/2020, GS017276 exp 02/2020, GS017045 exp 02/2020,GS016726 exp 02/2020, | 64,362 HDPE bottles |
| D-1284-2019 | Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx only GSMS Incorporated; GS015204 exp 06/ 2019, GS018318 exp 02/2020, GS014817 exp 06/2019, GS017342 exp 02/2020, GS017808 exp 02/2020 | 11,286 HDPE Bottles |
| D-1285-2019 | Losartan Potassium Tablets USP 100 mg 90 count bottle NDC 60429-318-90 Rx only GSMS Incorporated; GS014045,exp 06/2019, GS014305 exp 06/2019, GS014044 exp 0/2019, GS016535 exp 01/2020, GS016524 exp 01/2020, GS017384 exp 02/2020, GS017385 exp 01/2020, GS017539 exp 01/2020, GS017540 exp 01/2020, GS017543 exp 01/2020, GS017542 exp 01/2020 GS017984 exp 02/2020, GS017985 exp 02/2020, GS017986 exp 02/2020, GS018263 exp 02/2020, GS018264 exp 02/2020, GS018265 exp 02/2020 | 138,213 HDPE Bottles |
| D-1286-2019 | Losartan Potassium Tablets USP 100 mg 1000 count bottle NDC 60429-318-10 Rx only GSMS Incorporated; GS014054 exp 06/2019, GS016338 exp 12/2019, GS016341 exp 01/2020, GS016342 exp 01/2020, GS016343 exp 01/2020, GS016344 exp 01/2020, GS016345 exp 01/2020, GS016539 exp 01/2020, GS016969 exp 01/2020, GS016973 exp 01/2020, GS017337 exp 01/2020, GS018524 exp 02/2020 | 8,767 HDPE Bottles |
What to do — step by step
Check Product Label
Look for the NDC code 60429-316-30 on the tablet bottle label.
Questions people ask
Is this medication safe to take?
The FDA confirmed the presence of an impurity that exceeds safe levels, so it is not safe to take as recalled.
How can I get a replacement?
The recall record does not specify a replacement or remedy process.
What is the NDC code for this product?
The NDC code for the recalled product is 60429-316-30.
Contact Golden State Medical Supply
We’ve drafted a message you can send Golden State Medical Supply to request your refund or repair — edit it as you like.
Subject: Recall D-1282-2019 — Golden State Medical Supply Golden State Medical Supply Hello, I own a Golden State Medical Supply that is covered by recall D-1282-2019 from Golden State Medical Supply. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1282-2019 (May 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1282-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.